6 drug(s) with this reaction
9,469 total reports
Glossodynia has been reported as an adverse reaction across 6 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,469 adverse event reports mention glossodynia in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with glossodynia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have glossodynia listed in their FDA adverse event reports, sorted by report count:
In addition to glossodynia, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
6 drug(s) manufactured by Haleon Us Holdings Llc have glossodynia listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, STANNOUS FLUORIDE, POTASSIUM NITRATE, SODIUM FLUORIDE, SODIUM MONOFLUOROPHOSPHATE, and others.
There are a combined 9,469 reports of glossodynia across 6 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.